Antibiotic-associated changes in Akkermansia muciniphila alter its effects on host metabolic health

Yumin Han1, Teh Min Teng1, Juwon Han1

  • 1Division of Biosystems & Biomedical Sciences, College of Health Sciences, 145 Anam-Ro, Seongbuk-Gu, Seoul, 02841, Korea.

Microbiome
|February 7, 2025
PubMed
Abstract

Insights

Antibiotic exposure, like penicillin, can alter beneficial gut microbes such as Akkermansia muciniphila. These altered microbes show reduced ability to combat obesity, potentially linking antibiotic use to chronic conditions.

Area of Science:

  • Microbiome research
  • Gut health
  • Antibiotic effects

Background:

  • Altered gut microbiota is linked to chronic human diseases.
  • Antibiotic exposure, particularly penicillin, is a suspected driver of long-term microbiota changes.
  • The precise mechanisms connecting antibiotic-altered microbiota to chronic conditions are not fully understood.

Purpose of the Study:

  • To investigate the impact of penicillin exposure on the gut microbe Akkermansia muciniphila.
  • To identify genetic changes in A. muciniphila resulting from antibiotic exposure.
  • To assess the functional consequences of these changes on host health, specifically obesity mitigation.

Main Methods:

  • Exposure of a murine model to penicillin.
  • Identification of genetic variants in Akkermansia muciniphila.
  • Assessment of obesity mitigation capabilities in A. muciniphila variants using a murine model.

Main Results:

  • Penicillin exposure selected for variants of Akkermansia muciniphila.
  • These variants possessed mutations in TEM-type β-lactamase or pur genes involved in purine biosynthesis.
  • A. muciniphila variants demonstrated impaired ability to mitigate host obesity in mice.
  • These variants are globally prevalent in the human microbiome.

Conclusions:

  • Antibiotics can impair the beneficial functions of key gut microbes like A. muciniphila through genetic selection.
  • The widespread presence of these antibiotic-selected A. muciniphila variants may contribute to the global burden of chronic diseases.
  • Further human population studies are necessary to confirm the role of these variants in chronic condition epidemics.